CoreCap Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.72K | Hold |
41
| – | – | ﹤0.01% | 2460 |
|
|
2026
Q1 | $2.22K | Hold |
41
| – | – | ﹤0.01% | 2387 |
|
|
2025
Q4 | $2.3K | Hold |
41
| – | – | ﹤0.01% | 2445 |
|
|
2025
Q3 | $1.97K | Hold |
41
| – | – | ﹤0.01% | 2380 |
|
|
2025
Q2 | $1.66K | Hold |
41
| – | – | ﹤0.01% | 2345 |
|
|
2025
Q1 | $1.8K | Hold |
41
| – | – | ﹤0.01% | 2384 |
|
|
2024
Q4 | $1.76K | Sell |
41
-32
| -44% | -$1.46K | ﹤0.01% | 2265 |
|
|
2024
Q3 | $3.24K | Sell |
73
-13
| -15% | -$557 | ﹤0.01% | 2083 |
|
|
2024
Q2 | $3.42K | Sell |
86
-23
| -21% | -$932 | ﹤0.01% | 1226 |
|
|
2024
Q1 | $4.7K | Buy |
+109
| New | +$4.7K | ﹤0.01% | 1933 |
|
|
2022
Q4 | $20.4K | Buy |
+499
| New | +$20.8K | ﹤0.01% | 1294 |
|
|
2022
Q3 | – | Sell |
-585
| Closed | -$25K | – | 2141 |
|
|
2022
Q2 | $25K | Buy |
+585
| New | +$24.5K | ﹤0.01% | 1173 |
|
|
2022
Q1 | – | Sell |
-4
| Closed | -$1K | – | 2136 |
|
|
2021
Q4 | $1K | Buy |
+4
| New | +$190 | ﹤0.01% | 2291 |
|
Other funds holding XPH
FCBT
AWM
CI
FFA